Blog
RSS FeedPosted by Michael Wonder on 06 Aug 2016
CADTH calls for patient input on a submission from Cipher Pharmaceuticals for Actikerall (5-fluorouracil with salicylic acid)
5 August 2016 - CADTH is calling for patient input on a pending submission from Cipher Pharmaceuticals for Actikerall. ...
Posted by Michael Wonder on 03 Aug 2016
CADTH calls for patient input on a submission from Horizon Pharmaceuticals for Ravicti (glycerol phenylbutyrate)
2 August 2016 - CADTH has called for patient input from Horizon Pharmaceuticals for Ravicti. ...
Posted by Michael Wonder on 03 Aug 2016
CADTH calls for patient input on submission from Allergan for Fetzima (levomilnacipran hydrochloride)
2 August 2016 - CADTH is calling for patient input on a pending submission from Allergan for Fetzima. ...
Posted by Michael Wonder on 27 Jul 2016
CADTH calls for patient input on submission from Pierre Fabre for Hemangiol (propranolol hydrochloride)
27 July 2016 - CADTH has received notice of a pending submission from Pierre Fabre for Hemangiol (propranolol hydrochloride). ...
Posted by Michael Wonder on 11 Jun 2016
CADTH calls for patient input on submission from Teva for Fentora (fentanyl citrate)
10 June 2016 - CADTH calls for patient input on a submission from Teva Pharmaceuticals for Fentora (fentanyl citrate). ...
Posted by Michael Wonder on 08 Jun 2016
CADTH calls for patient input on submissions from Daiichi Sankyo for edoxaban tosylate
8 June 2016 - CADTH has received notice of pending submissions from Daiichi Sankyo for edoxaban tosylate. ...
Posted by Michael Wonder on 17 May 2016
Call for patient input on a submission from Boehringer Ingelheim for Praxbind
17 May 2016 - CADTH has received notice of a pending submission from Boehringer Ingelheim for Praxbind (idarucizumab) for the reversal ...
Posted by Michael Wonder on 04 May 2016
Call for patient input on a submission from Teva Pharmaceuticals for reslizumab
4 May 2016 - CADTH has received notice of a pending submission from Teva Pharmaceuticals for reslizumab for use by patients ...
Posted by Michael Wonder on 02 May 2016
Call for patient input on a submission from Raptor Pharmaceutical for Quinsair (levofloxacin hemihydrate)
2 May 2016 - CADTH has received notice of a pending submission from Raptor Pharmaceutical for Quinsair (levofloxacin hemihydrate) oral solution ...
Posted by Michael Wonder on 26 Apr 2016
Call for patient input on a submission from Ferring Pharmaceuticals for budesonide
26 April 2016 - CADTH has received notice of a pending submission from Ferring Pharmaceuticals for budesonide for use by patients ...
Posted by Michael Wonder on 04 Apr 2016
CADTH calls for patient input on submissions from Boehringer Ingelheim & Servier
4 April 2016 - CADTH has received notice of pending submissions from Boehringer Ingelheim for empagliflozin with metformin hydrochloride (Synjardy) for ...
Posted by Michael Wonder on 30 Mar 2016
Call for patient input on a submission from Boehringer Ingelheim for Jardiance (empagliflozin)
30 March 2016 - CADTH has received notice of a pending submission from Boehringer Ingelheim for empagliflizin (Jardiance) for use by ...
Posted by Michael Wonder on 25 Mar 2016
Introducing a common CADTH recommendation framework and establishing a minimum period of 120 calendar days for advance notification of anticipated submissions and resubmissions for CADTH Common Drug Review and pan-Canadian Oncology Drug Review Programs
23 March 2016 - CADTH will be implementing changes to the CDR Procedures and pCODR Procedures that will require all manufacturers/submitters ...
Posted by Michael Wonder on 24 Mar 2016
CADTH calls for patient input on a submission from Takeda for Entyvio (vedolizumab)
23 March 2016 - CADTH has received the following notice of a pending submission from Takeda for Entyvio (vedolizumab) for use ...
Posted by Michael Wonder on 23 Mar 2016
CADTH calls for patient input on a submission from Gilead for sofosbuvir with velpatasvir
23 March 2016 - CADTH has received notice of a pending submission from Gileda for sofosbuvir with velpatasvir for the treatment ...